Key Market Indicators
Luxembourg's vaccination coverage for children aged one year is projected to maintain a steady rate of 99% by 2028, the same figure as in 2023. This consistency reflects a trend observed since 1988, with no significant changes in the vaccination rates over the years. In terms of vaccine imports, Luxembourg is expected to see a substantial increase. By 2028, the country's vaccine imports are anticipated to reach approximately $11.8 million, up from about $9.9 million in 2023. This represents an average annual growth rate of 2.6%. Since 2004, Luxembourg's demand for vaccines has been rising at an average annual rate of 3.7%. Conversely, Luxembourg's vaccine exports are on a declining trajectory. By 2028, exports are forecasted to plummet to around $609, down from $3,180 in 2023, marking an average annual decrease of 25.6%. This decline has been ongoing since 2004, with the supply dropping by an average of 13.4% each year. In 2023, Luxembourg ranked 55th in vaccine exports, having been overtaken by Samoa which reported exports of $3,180. Leading the rankings were Belgium, the United Kingdom, and France, taking the second, third, and fourth positions respectively.
